PM

Priya Modak Biswas

Active Director Additional Director DIN 08777151
DIN 08777151 First appointment May 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Priya Modak Biswas

Data last updated:

Priya Modak Biswas is an Additional Director at Sevlok Pharmaceuticals Private Limited (since 2022). The company operates in Trading. Sevlok Pharmaceuticals Private Limited reported revenue of ₹40.5 Lakh (FY 2025).

DIN 08777151
Primary Designation Additional Director
Industry Trading
First Appointment 30 May 2022
Oldest Company Age 6 yrs
Largest company Sevlok Pharmaceuticals Private Limited · ₹40.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director30 May 20222020₹40.5 Lakh (FY 2025)Active

Board colleagues of Priya Modak Biswas

NameDINCompanyDesignation
Mir Masnat Ali09624266Sevlok Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Sevlok Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priya Modak Biswas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priya Modak Biswas

Priya Modak Biswas currently holds 1 directorship: Sevlok Pharmaceuticals Private Limited (Additional Director, since 30 May 2022, revenue ₹40.5 Lakh (FY 2025)).

Priya Modak Biswas was first appointed on 30 May 2022 as Additional Director at Sevlok Pharmaceuticals Private Limited.

The current boards of Priya Modak Biswas's companies include Mir Masnat Ali (Sevlok Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available